Proton VPN boss compares Switzerland to Russia and claims it could leave the country over proposed law
Proton boss Andy Yen has said the company will leave Switzerland if the country's new surveillance legislation becomes law.
Switzerland is known for its strong privacy laws and is home to one of the best VPNs, Proton VPN.
The law change would impact Proton VPN's credentials as one of the most private VPNs and would have a monumental effect on the wider VPN industry.
Switzerland's current surveillance law instructs mobile networks and internet service providers (ISPs) to collect and store user data. The proposed change would extend this to VPNs, messaging apps, and social media companies.
Having a strict no-logs policy is very important and a must-have to be considered a quality VPN provider. Collecting user information would severely breach these policies and undermine user privacy.
Proton VPN would rather leave its Swiss home than risk the privacy of its users.
The Swiss government's consultation on the proposals closed on May 6 2025, and we are awaiting its findings.
Andy Yen spoke to Radio Télévision Suisse (RTS) on May 13, and launched a scathing attack on the proposed legislative amendment.
Yen described it as a "major violation of the right to privacy" – something that directly contradicts Proton's "privacy by default" tagline.
"This revision attempts to implement something that has been deemed illegal in the EU and the United States," Yen claimed. "The only country in Europe with a roughly equivalent law is Russia."
This is a damning comparison. Russia has some of the world's strictest VPN laws, has banned multiple VPNs from its app stores, and has a long history of internet censorship. In December 2024, it disrupted the internet across several regions in a rumoured test of its "sovereign internet structure."
The only country in Europe with a roughly equivalent law is Russia
The amendment's consultation phase ended on May 6. At the time of writing the findings aren't known.
If the law is changed, Yen said "we would have no choice but to leave Switzerland."
"The law would become almost identical to the one in force today in Russia. It's an untenable situation. We would be less confidential as a company in Switzerland than Google, based in the United States. So it's impossible for our business model."
The law requires changes to encryption, as well as user data collection. An encryption backdoor would be demanded and new types of information and monitoring created.
Proton's users exceed 100 million, with Proton VPN, Proton Mail, and the wider Proton ecosystem at risk. But other Swiss based companies who provide encrypted services would also be impacted – including the encrypted messaging app, Threema, and the newly launched VPN, NymVPN.
NymVPN has been a vocal critic of the proposed amendment, with its Chief Operating Officer Alexis Roussel releasing a detailed statement.
We test and review VPN services in the context of legal recreational uses. For example: 1. Accessing a service from another country (subject to the terms and conditions of that service). 2. Protecting your online security and strengthening your online privacy when abroad. We do not support or condone the illegal or malicious use of VPN services. Consuming pirated content that is paid-for is neither endorsed nor approved by Future Publishing.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
35 minutes ago
- Business Wire
Debiopharm and Alkyon Therapeutics Announce Research Collaboration to Advance the Next Generation of Radioligand Therapies
MARTIGNY, Switzerland & LAUSANNE, Switzerland & SAN DIEGO--(BUSINESS WIRE)--Debiopharm ( a privately-owned Swiss biopharmaceutical company committed to establishing tomorrow's standard of care to cure cancer and infectious diseases and Alkyon Therapeutics, Inc., a biotechnology company pioneering precision-targeted therapies, today announced the signing of a co-research agreement to evaluate the feasibility of developing targeted radioligand therapies (RLTs) using Debiopharm's proprietary AbYlink™ conjugation technology for Alkyon's modular antibody platform directed against undisclosed tumor-associated antigens. This collaboration marks a promising step toward a new generation of RLTs designed to deliver potent radiation targeted directly to cancer cells while minimizing damage to healthy tissues. By leveraging the unique strengths of both platforms, the goal is to create more effective, better-tolerated cancer treatments that improve patient quality of life and expand therapeutic options for difficult-to-treat tumors. AbYLink™ technology enables regio-selective lysine conjugation, ensuring the radioligand avoids the target binding site and facilitating streamlined, consistent manufacturing. 'We're intrigued to explore the potential of applying AbYlink™ conjugation technology to the radio-oncology field,' expressed Frederic Levy, Chief Scientific Officer, Debiopharm. 'Leveraging our innovative conjugation platform with Alkyon's engineered antibody scaffolds could open new possibilities for next-generation radiopharmaceuticals with enhanced precision and therapeutic impact.' 'This collaboration reflects our shared commitment to expanding the potential of radioligand therapies,' said Benjamin Titz, Co-Founder and CEO of Alkyon Therapeutics. 'By applying AbYlink™ to our specialized antibody scaffolds and targeting strategies tailored to the unique architecture of solid tumors, we aim to unlock new therapeutic possibilities and advance care for patients with difficult-to-treat solid tumors.' About AbYlink™ AbYlink™ is a versatile and rapid regio-selective chemical conjugation technology for use in preparing diagnostic or therapeutic conjugates. This one-step method results in stable conjugation at defined and invariable sites on the Fc domain of an antibody or the like, with no impact on antigen-binding regions. It enables a seamless and reproducible conjugation of payloads (e.g., a chelator for radiolabeling, a fluorescent dye or a drug) to antibodies or ADCs. The universal applicability of the technology has been demonstrated for various antibody isotypes and payloads. About Alkyon Therapeutics, Inc. Alkyon Therapeutics, Inc. (AlkyonTx™) is a biotechnology company developing next-generation radioligand therapies (RLTs) for solid tumors. By combining precision-engineered antibodies with advanced radiochemistry and dosimetry technologies, Alkyon aims to overcome barriers such as immune exclusion and drug resistance in difficult-to-treat cancers. Its modular platform supports monotherapies, bispecifics, and rational combinations designed to enable differentiated clinical benefit and scalable product development. Debiopharm's commitment to patients Debiopharm aims to develop innovative therapies that target high unmet medical needs primarily in oncology and bacterial infections. Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential compounds and technologies for in-licensing, clinically demonstrate their safety and efficacy, and then hand stewardship to large pharmaceutical commercialization partners to maximize patient access globally. For more information, please visit
Yahoo
2 hours ago
- Yahoo
Controversial FIA statute changes voted through
Controversial changes to the statutes of Formula 1's governing body the FIA have been passed by members despite a warning the organisation is in a "dark period of democratic backsliding". Austria's national motoring club, the OAMTC, criticised the statute changes in a letter to the FIA World Council for Automobile Mobility and Tourism (WCAMT) sent on Wednesday before Thursday's vote at the FIA's General Assembly in Macau. The letter criticised FIA president Mohammed Ben Sulayem's leadership and urged members not to vote for changes proposed by Ben Sulayem - and revealed by BBC Sport last month - on the basis that they "risk further contributing to the erosion of the FIA's reputation for competent and transparent governance". However, members voted for the amendments by 83.35% to 16.65%. Amendments to the ethics code were voted through even more comprehensively, with an 88.83% majority. The result came despite support from the UK, Belgian, Portuguese and Swiss representatives for Austria's suggestion of a postponement so the FIA could conduct a "proper review and analysis" before making a decision on whether the changes were appropriate. An FIA spokesperson described the result as a "resounding majority" however it has not yet responded to a request for comment on the OAMTC letter. The OAMTC letter adds that recent actions of Ben Sulayem "are inviting comparisons with the excesses of political leaders intent on deconstructing the checks and balances that come with responsible governance". And it hints at the prospect of a legal challenge, on the basis that the changes were "endorsed by (FIA) world council meetings that were not properly constituted, having intentionally excluded elected members from participating and voting". David Richards, the MotorsportUK representative on the world council, was among those members barred from a meeting in March in a dispute with Ben Sulayem over refusing to sign a revised confidentially agreement. The OAMTC is led by Oliver Schmerold, who last year voiced his opposition to previous statute changes passed at the last General Assembly in December, describing them as "not good governance" and "not good in terms of checks and balances". The letter says of the proposed changes: Extending the deadline for potential candidates to declare "is intended to discourage opposition". Removing the rule requiring 21 of the 28 members of the world motorsport council to be different nationalities "is intended to stack the WMSC with supporters rather than encourage diversity of opinion" Aligning the terms of office of the audit, ethics and nominations committees with that of the president "would blatantly reduce the independence of oversight bodies" Removing the right to approve or dismiss up to four senate members from the senate and giving it to the president "self-evidently weakens the ability of the senate to perform its oversight functions, including and especially oversight of the president himself. Ben Sulayem's first term of office ends this December and he is so far the only candidate to have confirmed he is standing for election. Rally legend Carlos Sainz has said he is considering running but has not made a final decision. The letter accuses Ben Sulayem of reneging on his promises during his election campaign in 2021 to ensure "governance structures are compliant with best practices". And it says he has implemented none of the "critical changes" that were recommended by a review and audit of the FIA's governance structure commissioned from McKinsey in 2022. It highlights a series of changes that have eroded accountability at the FIA, including: Limiting the power of the ethics committee, saying "ethical enquiries can - in effect - be suppressed" because of the concentration of oversight into the hands of the FIA president and president of the senate. The eradication of the post of compliance office following the sacking of Paolo Basarri from that position last year Centralising decision-making power with the FIA president and president of the senate The imposition of contracts that require FIA personnel to pay a €50,000 fine if they breach confidentiality terms, and the power of the leadership on its own to determine whether this should be paid and why "without having a hearing, time frame, right of appeal or any definition of what confidentiality means".
Yahoo
2 hours ago
- Yahoo
The dollar's crown is slipping, and fast
By Dhara Ranasinghe and Amanda Cooper LONDON (Reuters) -The dollar has sunk to its lowest in three years as rapidly changing U.S. trade policy unsettles markets and expectations build for Federal Reserve rate cuts, fuelling outflows from the world's biggest economy. With the dollar down almost 10% against a basket of major currencies this year, other countries around the globe are grappling with unanticipated FX moves that are having a knock-on impact on economic growth and inflation. "There's clearly solid dollar selling," said Kit Juckes, chief FX strategist at Societe Generale. Here's a look at some of the biggest movers: 1/ CROWN JEWELS Scandinavia's currencies are the standout performers against the dollar so far in 2025. The Swedish crown is up 14%, its best performance at this point in the year against the U.S. currency in at least 50 years. Norway's crown is up nearly 12%, its best run since 2008. Highlighting just how much of this strength stems from dollar weakness, Sweden's crown is up only 4% against the euro and Norway's just 1.8%. Sweden is expected to cut rates this month as inflation and its economy slow, yet its currency shows no signs of weakening. In Norway, lower oil prices often temper the crown, but that dynamic has also been upended by its relationship with the dollar. 2/ SAFE-HAVEN WOES The euro, Swiss franc and Japanese yen are also among the biggest beneficiaries of the dollar's fall from grace, up roughly 10% each so far this year. But this comes at a price. Swiss inflation turned negative in May, marking the first decline in consumer prices for more than four years. The surge in the franc reduces the price of imported goods, and piles pressure on the central bank to cut rates back below 0%. European Central Bank rate setters will also have a wary eye on the single currency, which at around $1.1572 is at its highest since 2021. "In my heart-of-hearts we are going to get to $1.20 but we shouldn't get there too fast because it's deflationary," said SocGen's Juckes. Even after the recent surge, the yen remains down almost 30% from end-2020 levels, leaving Japan to try to balance the negatives of a stronger currency with the need to demonstrate in trade talks with Washington that it is not seeking an unfair advantage from its longer-term weakness. 3/ FACTORY ASIA For years, Asian investors parked trillions of dollars in U.S. assets such as Treasuries. U.S. President Donald Trump's April 2 "Liberation Day" fired the starting gun for that capital to start flowing back to the world's manufacturing powerhouses, boosting their currencies. Taiwan's dollar surged 10% over two days in May and is up nearly 12% this year, while the Korean won has gained around 10%. Singapore's dollar, Malaysia's ringgit and Thailand's baht are all up 6% too, but China's yuan - arguably the most exposed to tariffs - has only appreciated by about 2% offshore, hemmed in by the central bank's guardrails around its onshore counterpart. China wasn't labelled a manipulator in the U.S. Treasury's latest currency report, but the lag in the yuan will not have gone unnoticed in Washington. 4/ OUTLIER Argentina's peso is an outlier, down around 15% against the dollar and one of this year's weakest performers. The reasons are domestic with the introduction of a new exchange rate regime in April allowing the peso to float freely within a gradually expanding band that started between 1,000-1,400 pesos per dollar. Still, the chaotic crash feared by some has been avoided and a recent $20 billion loan agreement with the IMF is positive. In contrast, Mexico's peso, which was under particular pressure at the start of the year from U.S. trade policy, has bounced back to near its strongest levels since August. While it could gain further if tariff spats are resolved, it is also sensitive to the U.S. economic outlook. 5/ STERLING Softer data has raised the prospect of Bank of England rate cuts and capped sterling's recent rally to more than three-year highs against the dollar. The pound is up almost 9% this year and analysts say foreign buyers may be rushing to snap up UK Plc before any further dollar weakness makes future transactions more expensive. More than $10 billion in bids for British companies were announced on Monday, this year's busiest day, according to Dealogic data. Analysts do, however, expect sterling to underperform other major currencies bar the dollar, given fiscal worries and weakening growth. "Sterling is less appealing than others (currencies) and the macro risks are elevated," said Lloyds FX strategist Nick Kennedy. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
